| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM199705083361903 |
| P698 | PubMed publication ID | 9134875 |
| P50 | author | Daniel Levy | Q88264418 |
| Emelia J. Benjamin | Q28754501 | ||
| Ramachandran S. Vasan | Q30348351 | ||
| Martin G Larson | Q37390385 | ||
| P2093 | author name string | Evans JC | |
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| heart failure | Q181754 | ||
| congestive heart failure | Q19000661 | ||
| P304 | page(s) | 1350-1355 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. | |
| P478 | volume | 336 |
| Q63811737 | 70-year legacy of the Framingham Heart Study |
| Q43658607 | ABCD's of Heart Failure: Echo-ing through the First Stage |
| Q36174413 | Alström syndrome: cardiac magnetic resonance findings |
| Q47172052 | Anthropometric normalization of left ventricular size in chronic mitral regurgitation |
| Q46160863 | Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results |
| Q46242921 | Asymptomatic cardiac disease following mediastinal irradiation |
| Q34027559 | Asymptomatic left ventricular dysfunction in the community |
| Q28604084 | Atlas-based Anatomical Modeling and Analysis of Heart Disease |
| Q92105515 | BAOXIN Granules Protected Mouse Model With Elevated Afterload From Cardiac Hypertrophy by Suppressing Both Inflammatory Reaction and Collagen Deposition |
| Q28607069 | Big heart data: advancing health informatics through data sharing in cardiovascular imaging |
| Q40418816 | Biomass fuel smoke exposure was associated with adverse cardiac remodeling and left ventricular dysfunction in Peru |
| Q37407710 | Biventricular and novel pacing mechanisms in heart failure |
| Q36766666 | Brain Natriuretic Peptide in Liver Cirrhosis and Fatty Liver: Correlation with Cardiac Performance |
| Q61460190 | Brain natriuretic peptide as a marker of cardiac involvement in hypertension |
| Q54940281 | Cardiac eccentric remodeling in patients with rheumatoid arthritis. |
| Q40831915 | Cardiac remodeling as a consequence and cause of progressive heart failure. |
| Q51328101 | Cardiac remodeling as therapeutic target: treating heart failure with Cardiac Support Devices. |
| Q37776976 | Cardiac remodelling and myocardial recovery: lost in translation? |
| Q34721697 | Cardiac ventricular dimensions predict cognitive decline and cerebral blood flow abnormalities in aging men. |
| Q48224419 | Cardioprotection for Duchenne's muscular dystrophy |
| Q58842642 | Chagas' heart disease and the autonomic nervous system |
| Q34687362 | Chronic kidney disease and the risk of heart failure in men |
| Q34707756 | Classification of left ventricular size: diameter or volume with contrast echocardiography? |
| Q37503009 | Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology |
| Q52934198 | Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. |
| Q37388557 | Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study |
| Q35571144 | Diabetes and the risk of heart failure |
| Q35582125 | Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population |
| Q46391023 | Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood |
| Q92031308 | Dissemination and Implementation Program in Hypertension in Rwanda: Report on Initial Training and Evaluation |
| Q41627374 | Dynamic Relation of Changes in Weight and Indices of Fat Distribution With Cardiac Structure and Function: The Dallas Heart Study. |
| Q44276674 | Dyssynchrony in Obese Subjects without a History of Cardiac Disease Using Velocity Vector Imaging |
| Q42933188 | Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study |
| Q82420735 | Early predictors of cardiac decompensation in experimental volume overload |
| Q37255160 | Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney disease |
| Q35802753 | Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study |
| Q36380523 | Effects of cardiac resynchronization therapy on disease progression in chronic heart failure |
| Q37155986 | Effects of cardiac resynchronization therapy on ventricular remodeling |
| Q74291235 | Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure |
| Q49452423 | Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients |
| Q51710038 | Endothelial dysfunction, measured by reactive hyperaemia using strain-gauge plethysmography, is an independent predictor of adverse outcome in heart failure. |
| Q43818753 | Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. |
| Q33639278 | Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction |
| Q30857033 | Extraction of echocardiographic data from the electronic medical record is a rapid and efficient method for study of cardiac structure and function |
| Q37202129 | Familial aggregation of left ventricular geometry and association with parental heart failure: the Framingham Heart Study |
| Q73016833 | Familial dilated cardiomyopathy: echocardiographic diagnostic criteria for classification of family members as affected |
| Q24612121 | Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data |
| Q21093317 | Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study |
| Q64092953 | Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure |
| Q34270883 | Global surgical experience with the Acorn cardiac support device |
| Q57308718 | Goals and guidelines for treating hypertension in a patient with heart failure |
| Q37637447 | Heart Failure in Women--Insights from the Framingham Heart Study |
| Q36123735 | Heart failure following anterior myocardial infarction: an indication for ventricular restoration, a surgical method to reverse post-infarction remodeling |
| Q57023689 | High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy |
| Q33906965 | Human K(ATP) channelopathies: diseases of metabolic homeostasis |
| Q37335867 | Hypertension and heart failure: a dysfunction of systole, diastole or both? |
| Q28511919 | Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A |
| Q52676301 | Imaging technologies for cardiac fiber and heart failure: a review. |
| Q52252113 | Impact of contrast echocardiography on diagnostic algorithms: pharmacoeconomic implications. |
| Q73407986 | In-hospital heart failure, first-year ventricular dilatation and 10-year survival after acute myocardial infarction |
| Q33478347 | Increase in end-systolic volume after exercise independently predicts mortality in patients with coronary heart disease: data from the Heart and Soul Study |
| Q51994063 | Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure. |
| Q36984053 | K(ATP) channel polymorphism is associated with left ventricular size in hypertensive individuals: a large-scale community-based study |
| Q38732534 | Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function |
| Q89537293 | Left Ventricular End-Diastolic Diameter and Cardiac Mortality in Duchenne Muscular Dystrophy |
| Q55026521 | Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction. |
| Q34603562 | Left ventricular dilation and incident congestive heart failure in asymptomatic adults without cardiovascular disease: multi-ethnic study of atherosclerosis (MESA). |
| Q37434977 | Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction |
| Q30483594 | Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study |
| Q34091939 | Left ventricular shape variation in asymptomatic populations: the Multi-Ethnic Study of Atherosclerosis |
| Q36301208 | Left ventricular size and shape: determinants of mechanical signal transduction pathways |
| Q34433298 | Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging |
| Q35238190 | Left ventricular volume: an optimal parameter to detect systolic dysfunction on prospectively triggered 64-multidetector row computed tomography: another step towards reducing radiation exposure |
| Q73870544 | M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study) |
| Q42115618 | Material properties of CorCap passive cardiac support device |
| Q35772103 | Metabolic syndrome and risk for heart failure in middle-aged men. |
| Q99252421 | Metabolomic signatures of cardiac remodelling and heart failure risk in the community |
| Q37738230 | Mitral valve repair: What the ACORN Trial taught us. |
| Q37641414 | Modulation of left ventricular dilation remodeling with epicardial restraint devices in postmyocardial infarction heart failure |
| Q24812557 | Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis |
| Q38780883 | Myocardial reverse remodeling: how far can we rewind? |
| Q48548331 | Natriuretic peptides as indicators of cardiac remodeling in hypertensive patients |
| Q34795979 | Obesity and left ventricular dilatation in young adulthood: the Bogalusa Heart Study |
| Q36915912 | Obesity cardiomyopathy: diagnosis and therapeutic implications |
| Q97645765 | Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy |
| Q37373506 | Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy |
| Q35146909 | Pathogenetic basis of myocardial dysfunction and amenability to reversal |
| Q34239875 | Pathophysiology of chronic heart failure |
| Q78032668 | Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy |
| Q50036967 | Plasma MicroRNA Clusters in Human Left Ventricular Remodeling: A Biomarker and Discovery Platform |
| Q44930558 | Plasma parathyroid hormone and risk of congestive heart failure in the community |
| Q73661222 | Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study |
| Q35586408 | Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study). |
| Q48529037 | Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy |
| Q28652887 | Prioritizing causal disease genes using unbiased genomic features |
| Q30490011 | Prognostic value of left ventricular end-systolic volume index as a predictor of heart failure hospitalization in stable coronary artery disease: data from the Heart and Soul Study |
| Q38692507 | Progression of Coronary Artery Calcium and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis |
| Q36981830 | Raf-mediated cardiac hypertrophy in adult Drosophila |
| Q33973013 | Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent tr |
| Q34014145 | Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascular events MESA (multi-ethnic study of atherosclerosis). |
| Q43235380 | Regulation of matrix metalloproteinases is at the heart of myocardial remodeling |
| Q53510180 | Residual stress ischaemia is associated with blood markers of myocardial structural remodelling. |
| Q28264330 | Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure |
| Q51691320 | Reverse remodeling of the failing ventricle: surgical intervention with the Acorn Cardiac Support Device. |
| Q36942884 | Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease |
| Q45420213 | Role of electrocardiography and echocardiography in prevention and predicting outcome of subjects at increased risk of heart failure |
| Q34816965 | Screening for left ventricular dysfunction: a step too far? |
| Q35562157 | Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure |
| Q36473364 | Screening for ventricular remodeling |
| Q48493913 | Sleep disturbances independently predict heart failure in overweight middle-aged men. |
| Q57130816 | Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification |
| Q38059618 | Surgical ventricular restoration for the treatment of heart failure |
| Q78032634 | Surrogate end points in heart failure |
| Q39453635 | Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population |
| Q80453584 | Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats |
| Q34157841 | The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective |
| Q35160106 | The cardiac support device and the myosplint: treating heart failure by targeting left ventricular size and shape |
| Q37130785 | The epidemiology of congestive heart failure: the Framingham Heart Study perspective. |
| Q52666783 | The impact of menopausal hormone therapy (MHT) on cardiac structure and function: Insights from the UK Biobank imaging enhancement study. |
| Q34443705 | The looming polypharmacy crisis in the management of patients with heart failure. Potential solutions |
| Q35105820 | The new epidemiology of heart failure |
| Q34221022 | The risk of congestive heart failure: sobering lessons from the Framingham Heart Study |
| Q35566135 | The role of brain natriuretic peptide in population screening |
| Q37820086 | The role of imaging and molecular imaging in the early detection of metabolic and cardiovascular dysfunctions. |
| Q30833466 | Titin-truncating variants affect heart function in disease cohorts and the general population. |
| Q74296909 | Underutilization and clinical benefits of angiotensin-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction |
| Q48366367 | Unusual left ventricular dilatation without functional or biochemical impairment in normotensive extremely overweight Japanese professional sumo wrestlers |
| Q30412437 | Validation study of candidate single nucleotide polymorphisms associated with left ventricular hypertrophy in the Korean population |
| Q35626128 | Ventricular remodeling |
| Q77802811 | Ventricular remodeling. Mechanisms and prevention |
| Q34074729 | beta-blockers in heart failure: recently completed and ongoing clinical trials |
Search more.